ReviewCancers2025

Prognostic Value of Circulating Tumor DNA in HR+/HER2- Stage I-III Breast Cancer: A Systematic Review.

Ismail Ajjawi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.